DIGOXIN
| Digoxin is widely prescribed for the treatment of Congestive heart failure and disturbances of cardiac rhythm. Equilibrium of serum and tissue Digoxin levels occurs at 6 to 8 hours, hence blood specimens should be drawn atleast 6 to 8 hours after drug administration. The drug has a narrow therapeutic window which makes monitoring therapy mandatory. Symptoms of toxicity mimic Cardiac arrhythmias for which the drug is originally prescribed |
Pre-test Information : Specify sample drawn – whether Trough or Peak. Trough: just before the next dose is due at steady state. Peak : 6–8 hours after dose |
|---|
Report Delivery : Daily |
DIGOXIN
| Test Code | D-14 |
|---|---|
| Test Description | **DIGOXIN |
| Clinical Category | THERAPEUTIC DRUG MONITORING |
| Sample | 2 mL (1 mL min.) serum . Do not use SST gel barrier tubes. Separate serum within 2 hours of collection. . Trough: just before the next dose is due at steady state. Peak : 6–8 hours after dose |
| Method/Technology | Chemiluminescent Immunoassay |
| Storage/Temp | |
| Reporting Time | Daily |